Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from Nasdaq

How To Attend Lindblad Expeditions Q1 2022 Earnings Conference Call

Lindblad Expeditions (NASDAQ:LIND) will host a conference call at 08:30 AM ET on May 3, 2022, to discuss Q1 2022 earnings results.

Benzinga

How To Attend Seres Therapeutics Q1 2022 Earnings Conference Call

Seres Therapeutics (NASDAQ:MCRB) will host a conference call at 08:30 AM ET on May 4, 2022, to discuss Q1 2022 earnings results.

Benzinga

10 Communication Services Stocks With Whale Alerts In Today's Session

This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity scanner.

Benzinga

From analysis to the latest developments in health,
read the most diverse news in one place.

10 Consumer Discretionary Stocks With Whale Alerts In Today's Session

Benzinga

10 Information Technology Stocks Whale Activity In Today's Session

Benzinga

Looking At MercadoLibre's Recent Whale Trades

A whale with a lot of money to spend has taken a noticeably bullish stance on MercadoLibre. Looking at options history for MercadoLibre (NASDAQ:MELI) we detected 23 strange trades.

Benzinga

12 Information Technology Stocks Moving In Friday's Intraday Session

Gainers

Benzinga

Read news from The Economist, FT, and more,
with one subscription

$1000 Invested In Starbucks 15 Years Ago Would Be Worth This Much

Starbucks (NASDAQ:SBUX) has outperformed the market over the past 15 years by 4.27% on an annualized basis producing an average annual return of 11.3%. Currently, Starbucks has a market capitalization of $87.01 billion.

Benzinga

How To Attend Lee Enterprises Q2 2022 Earnings Conference Call

Lee Enterprises (NASDAQ:LEE) will host a conference call at 10:00 AM ET on May 5, 2022, to discuss Q2 2022 earnings results.

Benzinga

Why These Analysts Are Bullish On Gilead's Q1 Earnings

RBC Capital Market views Gilead Sciences Inc's (NASDAQ:GILD) Q1 as a solid quarter, with a bottom-line beat reflecting Veklury cash flow boost, solid core business performance despite seasonal headwinds, and in-line operating expenses. The analyst notes that the story remains somewhat catalyst light, especially with transformative M&A likely off the table. HIV sales,…

Benzinga

7 Stocks Moved By Traders On 'Fast Money: Halftime Report'

CNBC’s "Fast Money: Halftime Report" delivers market-moving news to investors.

Benzinga

Preview: Itron's Earnings

Itron (NASDAQ:ITRI) is set to give its latest quarterly earnings report on Monday, 2022-05-02. Here's what investors need to know before the announcement. Analysts estimate that Itron will report an earnings per share (EPS) of $0.08.

Benzinga

How To Learn From Cathie Wood's Mistakes Or Risk Massive Underperformance

Cathie Wood's investment strategy deserves some attention. Not because it should be modeled, but because investors can learn from the Ark Invest CEO's mistakes and hope to avoid falling into the same traps.

Benzinga

Expert Ratings for First Solar

First Solar (NASDAQ:FSLR) has observed the following analyst ratings within the last quarter:

Benzinga

Get all your
news in one place.

100's of premium titles.
One news app.

Benzinga

Earnings Outlook For Cardlytics

Cardlytics (NASDAQ:CDLX) is set to give its latest quarterly earnings report on Monday, 2022-05-02. Here's what investors need to know before the announcement. Analysts estimate that Cardlytics will report an earnings per share (EPS) of $-0.55.

Benzinga

SolarEdge Technologies's Earnings: A Preview

SolarEdge Technologies (NASDAQ:SEDG) is set to give its latest quarterly earnings report on Monday, 2022-05-02. Here's what investors need to know before the announcement. Analysts estimate that SolarEdge Technologies will report an earnings per share (EPS) of $1.28.

Benzinga

Expert Ratings for Alnylam Pharmaceuticals

Over the past 3 months, 10 analysts have published their opinion on Alnylam Pharmaceuticals (NASDAQ:ALNY) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a company's business to predict how a stock will trade over the upcoming year.

Benzinga

Preview: Rambus's Earnings

Rambus (NASDAQ:RMBS) is set to give its latest quarterly earnings report on Monday, 2022-05-02. Here's what investors need to know before the announcement. Analysts estimate that Rambus will report an earnings per share (EPS) of $0.37.

Get all your
news in one place.

100's of premium titles.
One news app.

Benzinga

Check Out What Whales Are Doing With AVGO

A whale with a lot of money to spend has taken a noticeably bearish stance on Broadcom. Looking at options history for Broadcom (NASDAQ:AVGO) we detected 31 strange trades.

Benzinga

Preview: Freshpet's Earnings

Freshpet (NASDAQ:FRPT) is set to give its latest quarterly earnings report on Monday, 2022-05-02. Here's what investors need to know before the announcement. Analysts estimate that Freshpet will report an earnings per share (EPS) of $-0.39.

Benzinga

$1000 Invested In Gilead Sciences 20 Years Ago Would Be Worth This Much

Gilead Sciences (NASDAQ:GILD) has outperformed the market over the past 20 years by 7.56% on an annualized basis producing an average annual return of 14.71%. Currently, Gilead Sciences has a market capitalization of $75.20 billion.

Benzinga

Peering Into Walgreens Boots Alliance's Recent Short Interest

Walgreens Boots Alliance's (NASDAQ:WBA) short percent of float has risen 16.8% since its last report. The company recently reported that it has 20.31 million shares sold short, which is 2.85% of all regular shares that are available for trading.

Benzinga

Analyst Ratings for Sprouts Farmers Market

Over the past 3 months, 4 analysts have published their opinion on Sprouts Farmers Market (NASDAQ:SFM) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a company's business to predict how a stock will trade over the upcoming year.

Benzinga

ArcBest Clocks 61% Revenue Growth In Q1, Beats Street Expectation

ArcBest Corp (NASDAQ:ARCB) reported first-quarter FY22 revenue growth of 61% year-over-year to $1.34 billion, beating the consensus of $1.26 billion. Adjusted EPS improved to $3.08 from $1.06 in 1Q21, beating the consensus of $2.15. Sales by segments: Asset-Based $705.31 million (+26.8% Y/Y), and Asset-Light $673.66 million (+116.3% Y/Y). The operating income increased…

Benzinga

Insurance Stocks Moving In Friday's Intraday Session

According to Benzinga Pro following are the gainers and losers in Insurance industry for today's Intraday session.

1 … 610 611 612 613

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Walgreens Boots Alliance

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.